Articles for author: Russ Cohen

Russ Cohen

Most Popular

The Shifting Sands of Investment: Nvidia Stock Sales and the Rise of Ford The Shifting Sands of Investment: Nvidia Stock Sales and the Rise of Ford

There’s no doubt about the sizzling journey of Nvidia (NASDAQ: NVDA) through the era of generative artificial intelligence (AI). The GPU and AI hardware specialist has been akin to a supernova in the investment cosmos, catapulting its market capitalization into the stratosphere since the advent of ChatGPT, leaving other stocks in the dust. The meteoric ...

Russ Cohen

Most Popular

Alibaba Expands Logistics Services With Alibaba Guaranteed Expanding Horizons: Alibaba Introduces Alibaba Guaranteed

Alibaba’s international business-to-business (B2B) e-commerce arm, Alibaba.com, has unveiled Alibaba Guaranteed to cater to global small and medium-sized enterprises (SMEs). Alibaba Guaranteed serves as a platform simplifying B2B cross-border trade for SMEs, ensuring supply chain reliability. The platform offers secure sourcing of products at fixed prices, with a commitment to delivery within 72 hours. Additionally, ...

Russ Cohen

Most Popular

The Unveiling of July 26th Options for Tesla Inc

Exploring the Intricacies of Trading Opportunities Like a seasoned artist unveiling a series of intricate brushstrokes, investors at Tesla Inc welcomed the trading debut of new options slated to expire on July 26th. As the financial stage was set, one put and one call contract emerged, capturing the attention of keen-eyed market participants. A Glimpse ...

Russ Cohen

Most Popular

Dianthus Therapeutics Launches Phase 2 Trial for DNTH103 A New Chapter: Dianthus Therapeutics Initiates Phase 2 Trial for DNTH103

Grandbrothers/iStock Editorial via Getty Images Dianthus Therapeutics (NASDAQ:DNTH) revealed on Wednesday that the U.S. FDA has greenlit its investigational new drug (IND) application, paving the way for the commencement of a Phase 2 trial for DNTH103, its premier asset aimed at addressing multifocal motor neuropathy (MMN), a rare neuromuscular disorder. The Phase 2 trial, named ...

Russ Cohen

Most Popular

Exploring the Impact of Apple’s Apple Intelligence Presentation on AAPL Stock

The Apple Intelligence Unveiling Apple (AAPL) unveiled Apple Intelligence, a cutting-edge personal intelligence system integrated into iOS 18, iPadOS 18, and macOS Sequoia, during its annual Worldwide Developers Conference. This innovative system, leveraging generative models, aims to streamline user experience across iPhone, iPad, and Mac devices by blending advanced language and image interpretation with personal ...

Russ Cohen

Most Popular

Unlocking the Potential: A Closer Look at Amazon’s Investment Opportunities

Amazon: A Pandemic-Era Investment Powerhouse Investors worldwide have kept a keen eye on Amazon – the colossal e-commerce entity that has captivated households globally with its Prime subscription service. As the unchallenged leader in U.S. online retail with a staggering 38% market share, Amazon has orchestrated a strategic network of distribution centers, vehicles, and aircraft ...

Russ Cohen

Most Popular

How to Play Adobe Stock Ahead of Its Q2 Earnings?

Investors Eyeing Adobe Stock Performance Ahead of Q2 Earnings The Stage Is Set for Adobe’s Q2 Earnings Report As Adobe prepares to unveil its second-quarter fiscal 2024 results on Jun 13, investors are eagerly waiting to see how the company performs in a market where innovative prowess and strategic positioning are paramount. Revenue and Earning ...

Russ Cohen

Most Popular

Nvidia: The Unseen Horizons Nvidia: The Unseen Horizons

Throughout the last decade, Nvidia (NASDAQ: NVDA), known for its superchip prowess, has left investors in awe with its stellar performance, vastly outshining the S&P 500 index. An initial $1,000 invested in Nvidia during this period has magnified into a colossal fortune exceeding a remarkable $255,000. In stark contrast, a similar amount allocated to a ...